The Effect of Exposure to Maternal Human Milk Odor on Physiological State of Preterms.
NCT ID: NCT01012505
Last Updated: 2009-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Provision of the odor and taste of the mother's milk has been shown to facilitate the infant's mouthing, sucking, arousal, and calming from irritability, especially in preparation for oral feeding. Using 24 hour monitor analysis and cortisol saliva measurements, we will provide quantitive analysis to the effect of smell.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Maternal Scent and Preterm Infant Nutrition
NCT03849248
The Effect of Breast Milk Smell on Nutrition in Preterms
NCT04843293
Analgesic Effect of Maternal Breast Milk Odor in Preterm Neonates: a Randomised Controlled Trial
NCT02381691
Melatonin Degradation Rate in Human Milk
NCT03591341
Effect of Early Feeding of Breast Milk
NCT03498989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
20 preterm infants
20 preterm infants without active disease
adding pad with maternal milk in hte incubator
2 days prior to intervention - recording infants data and taking saliva cortisol adding pad with maternal milk - during 2 days - recording infants data and taking saliva cortisol.
stopping intervention and for other 2 days recording infants data and taking saliva cortisol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
adding pad with maternal milk in hte incubator
2 days prior to intervention - recording infants data and taking saliva cortisol adding pad with maternal milk - during 2 days - recording infants data and taking saliva cortisol.
stopping intervention and for other 2 days recording infants data and taking saliva cortisol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no active disease or treatment (like respiratory support)
* place in incubator
Exclusion Criteria
7 Days
4 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tel Aviv University
OTHER
Sheba Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sheba Medical Cener
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sheba medical center
Ramat Gan, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHEBA-09-7392-AM-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.